Newark, New Castle, USA, May 31, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global 5-alpha-reductase inhibitors (5-ARIs) market was conducted by Growth Plus Reports in 2022. The market is ...

Compared to placebo treatment, taking 5-alpha-reductase inhibitors (5-ARIs) can reduce a man's risk of being diagnosed with prostate cancer from around 5--9% to around 4-6% during up to 7 years of ...

This article presents background information and highlights key findings from a managed care perspective related to enlarged prostate (EP) in Medicare-eligible patients. This article does not ...

Back to Healio A recent study found prior use of 5-alpha-reductase inhibitors for benign prostatic hyperplasia was associated with delayed prostate cancer diagnosis and worse prostate cancer outcomes.

Using 5α- reductase inhibitors was not associated with increased suicide risk in a group of older men but risks for self-harm and depression were increased during the 18 months after medication ...

Finasteride is in a class of medications called 5-alpha reductase inhibitors, or 5α-reductase inhibitors. They work by inhibiting the effects of an enzyme known as 5-alpha reductase, which ...

5-alpha reductase inhibitors block the production of the male sex hormone dihydrotestosterone, which accumulates in the prostate and may cause the prostate to grow. Finasteride and dutasteride are ...

Participants ranged from 18 to 83 years old and were taking 5-alpha-reductase inhibitors like finasteride and dutasteride, which is also used to treat prostate enlargement. Across all studies ...

BPH symptoms may be treated with medication. BPH drugs don’t cure the condition, but they may slow down the growth of your prostate. Benign prostatic hyperplasia (BPH) is a condition that ...

The risk comes with the entire class of 5-alpha reductase inhibitor (5-ARI) drugs. Known by the brand names Proscar, Avodart, Propecia and Jalyn, 5-ARIs are commonly prescribed as generic ...